OPTI — Opticept Technologies AB Balance Sheet
0.000.00%
- SEK114.00m
- SEK158.17m
- SEK54.47m
Annual balance sheet for Opticept Technologies AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 68 | 94.7 | 14.1 | 21.7 | 2.61 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 13.2 | 10.3 | 1.82 | 7.97 | 19.3 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 97.6 | 141 | 62.1 | 74 | 51.6 |
| Net Property, Plant And Equipment | 7.03 | 6.41 | 3.34 | 6.52 | 4.84 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 436 | 473 | 378 | 392 | 369 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 19.6 | 70.8 | 30.4 | 24.5 | 83.2 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 29.3 | 77.3 | 37 | 30.1 | 89.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 406 | 396 | 341 | 362 | 279 |
| Total Liabilities & Shareholders' Equity | 436 | 473 | 378 | 392 | 369 |
| Total Common Shares Outstanding |